Your institution may have access to this item. Find your institution then sign in to continue.
Title
<sup>18</sup>F-AlF-NOTA-octreotide outperforms <sup>68</sup>Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study.